Ipratropium- and salbutamol-containing product
RxNorm 214199
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 214199 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Ipratropium- and salbutamol-containing product.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MINPrescribable
Multiple Ingredients (MIN):
Albuterol / ipratropium
(Atom ID: 12352846)
PTPrescribable
Designated preferred name (PT):
Albuterol- and ipratropium-containing product
(Atom ID: 10795830)
SYPrescribable
Synonym (SY):
Ipratropium- and salbutamol-containing product
(Atom ID: 10805357)
FNPrescribable
Full form of descriptor (FN):
Product containing ipratropium and salbutamol (medicinal product)
(Atom ID: 9724687)
Patient Education
Albuterol and Ipratropium Oral Inhalation
The combination of albuterol and ipratropium is used to prevent wheezing, difficulty breathing, chest tightness, and coughing in people with chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to the air sacs in the lungs). Albuterol and ipratropium combination is used by people whose symptoms have not been controlled by a single inhaled medication. Albuterol and ipratropium are in a class of medications called bronchodilators. Albuterol and ipratropium combination works by relaxing and opening the air passages to the lungs to make breathing easier.
[Learn More]
* Please review the disclaimer below.